Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Adroit collaboration: Recipharm teams with solid state formulation firm

26-Mar-2015 - Swedish CMO Recipharm has teamed up with formulations and solid state chemistry firm Adroit Science in a strategic collaboration.

Growth with aid of Grey: Elderly folks to drive excipients sector, study

24-Mar-2015 - Demand for pensioner friendly pills will be an important growth driver for the drug excipients sector according to new analysis.

Rentschler brings single-use system online

23-Mar-2015 - Rentschler Biotechnologie has increased single-use bioreactor capacity at its manufacturing site in Laupheim, Germany and is moving forward with plans to invest €25m ($27m) in a new stainless steel system...

News in brief

Nanobiotix appoints CordenPharma as CMO for potential nanoparticle-based cancer treatment

19-Mar-2015 - The late clinical-stage nanomedicine company Nanobiotix has selected CordenPharma as its contract manufacturing partner. 

ImmunoCellular taps PharmaCell to manufacture dendritic cell-based vaccine for trial

19-Mar-2015 - European CMO PharmaCell B.V. has finalized an agreement with ImmunoCellular Therapeutics to support its pivotal phase III clinical trial in Europe with ICT-107, a dendritic cell-based vaccine in development for...

Exclusive interview

Rise in outsourcing to lead to further CMO consolidation, DPx CEO says

18-Mar-2015 - The CMO (contract manufacturing organization) industry is ripe for consolidation as the rise in outsourcing continues and clients look to simplify their supply chains, DPx CEO James Mullen told


WuXi to more than double US cell therapy manufacturing ops with new site

12-Mar-2015 - China-based CDMO WuXi PharmaTech unveiled Thursday that it will soon begin construction on its third cell therapy manufacturing facility -- a 145,000-square-foot cGMP facility in Philadelphia. 

WHO: Smart needles key to preventing new hep B infections

12-Mar-2015 - New hepatitis B treatment guidelines advocate use of Gilead and BMS drugs and underline WHO concerns that needle reuse spreads the virus.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

11-Mar-2015 - Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president...

Penn invests in pill tech citing industry demand

11-Mar-2015 - Penn Pharma has added new tablet making technology at its facility in Tredegar, Wales citing drug industry demand for dry granulation manufacturing capacity.

Orgenesis buys cell therapy CMO to cut manufacturing costs and diversify revenue stream

11-Mar-2015 - Orgenesis has bought Masthercell SA to take control of production of its Type 1 diabetes cell therapy candidate ahead of clinical trials.

Patheon focuses on solubility with acquisition of Oregon-based CDMO

09-Mar-2015 - For the second time in just over a week, CDMO Patheon has made an acquisition, this time for Agere Pharmaceuticals, a privately held CDMO based in Bend, Oregon, that specializes...

Anthrax vaccine stability data delivers contract extension for Glide Technologies

09-Mar-2015 - US desire for an alternative to the current multi-shot anthrax vaccine is a boon for delivery systems firm Glide Technologies, which had its contract extended by Pfenex this week.

CDMO Rottendorf signs five new projects with top biopharma companies

06-Mar-2015 - Chicago-based Rottendorf Pharmaceuticals, a top 20 contract development and manufacturing organization (CDMO), has signed three formulation development projects and two commercial transfer projects with multiple top pharma and biotech companies...

Patheon: Irix deal about US and Canadian customer demand for local APIs; all staff to be retained

05-Mar-2015 - Irix Pharmaceuticals will cater for North American customers’ desire for local supply according to Patheon, which says it plans to retain the API firm’s 180 staff.

Patheon has bought hard-to-make API specialist Irix Pharmaceuticals

04-Mar-2015 - Patheon has bought hard-to-manufacture active pharmaceutical ingredient (API) specialist, Irix Pharmaceuticals.

Valeant sacks Dendreon admin staff and plans manufacturing savings

04-Mar-2015 - Valeant has started cutting jobs at Provenge manufacturer Dendreon just over a week after it acquired the bankrupt firm for $495m (€444m).

CMO group wants US FDA fees to be exempt from enforced budget cuts

03-Mar-2015 - A US CMO industry group has backed plans to exempt privately paid user fees from Government spending cuts enforced if US politicians fail to agree a budget.

Sun Pharma goes after opiates with deal to buy GSK’s Aus business

03-Mar-2015 - Indian giant Sun Pharma has bought GSK’s Australian Opiates business.

UK R&D firm patents biologics powder storage technique

27-Feb-2015 - XstalBio, a private biopharma services company, has patented the use of stabilisers in the manufacture of dry powders for biopharmaceuticals – an alternative to freeze-drying or spray-drying techniques.

Japanese companies acquire CMO KBI Biopharma

26-Feb-2015 - Tokyo-based CMIC Holdings Co., Innovation Network Corporation of Japan (INCJ), and JSR have agreed to acquire KBI Biopharma, a contract development and manufacturing organization with facilities in Durham and Research...

News in brief

Bayer manufactures for biologics start-up in CoLaborator project

26-Feb-2015 - Bayer has announced a strategic alliance to manufacture a preclinical candidate for small biotech Aronora.

Sagent shifts production in-house after US FDA concerns about CMO Emcure

25-Feb-2015 - Problems at Emcure Pharmaceutical have prompted US customer Sagent Pharmaceuticals to recall two lots of a muscle relaxant made by the CMO and take production in-house.

Catalent wants to raise $630m through follow on offering

24-Feb-2015 - Catalent wants to raise $629.3m (EUR550m) through a follow-on offering that will see Blackstone sell 17.6m shares.

Syringe reuse not clever: WHO advocates use of "smart" syringes to stop disease spread

23-Feb-2015 - ‘Smart’ syringes that can’t be reused should be the drug and vaccine delivery technology of choice for healthcare programmes according to the WHO, which says needle reuse is spreading deadly...